PLSE
PULSE BIOSCIENCES, INC.
Overview
PULSE BIOSCIENCES, INC is a Healthcare company operating in Medical Instruments & Supplies with a $1.77B market cap.
PLSE missed consensus EPS by 0.1% in Q1 FY2026, reported May 3, 2026.
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from SEC 10-K filing, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-05-073 Q&A exchanges
- Q4 FY2025Earnings2026-02-207 Q&A exchanges
- Q3 FY2025Earnings2025-11-054 Q&A exchanges
- Q2 FY2025Earnings2025-08-127 Q&A exchanges
- Q1 FY2025Earnings2025-05-10
- Q4 FY2024Earnings2025-03-271 Q&A exchange
- Q3 FY2024Earnings2024-10-301 Q&A exchange
- Q2 FY2024Earnings2024-08-124 Q&A exchanges
- Q1 FY2024Earnings2024-05-075 Q&A exchanges
- Q4 FY2023Earnings2024-03-283 Q&A exchanges
- Q3 FY2023Earnings2023-11-1310 Q&A exchanges
- Q2 FY2023Earnings2023-08-103 Q&A exchanges
- Q1 FY2023Earnings2023-05-1111 Q&A exchanges
- Q4 FY2022Earnings2023-03-306 Q&A exchanges
- Q3 FY2022Earnings2022-11-101 Q&A exchange
- Q2 FY2022Earnings2022-08-1011 Q&A exchanges
- Q1 FY2022Earnings2022-05-1112 Q&A exchanges
- Q4 FY2021Earnings2022-03-3115 Q&A exchanges
- Q3 FY2021Earnings2021-11-1512 Q&A exchanges
- Q2 FY2021Earnings2021-08-0912 Q&A exchanges
- Q1 FY2021Earnings2021-05-109 Q&A exchanges
History
Earnings history
- Q1 FY20262026-05-03EPS$-0.24 vs $-0.22-9.7%Rev$401.0K vs ——EODHD
- Q4 FY20252026-02-19EPS$-0.18 vs $-0.21+14.3%Rev$264.0K vs ——EODHD
- Q3 FY20252025-10-28EPS$-0.29 vs $-0.31+6.5%Rev$86.0K vs ——EODHD
- Q2 FY20252025-08-11EPS$-0.28 vs $-0.26-7.7%Rev$0 vs ——EODHD
- Q1 FY20252025-05-04EPS$-0.25 vs ——Rev$832.0K vs ——EODHD
- Q4 FY20242025-03-25EPS$-0.31 vs $-0.24-30.2%Rev$1.7M vs ——EODHD
- Q3 FY20242024-10-29EPS$-0.21 vs $-0.24+13.5%Rev$0 vs ——EODHD
- Q2 FY20242024-08-18EPS$-0.20 vs $-0.20+0.4%Rev$0 vs ——EODHD
- Q1 FY20242024-05-06EPS$-0.18 vs $-0.24+23.5%Rev$0 vs ——EODHD
- Q4 FY20232024-03-27EPS$-0.22 vs $-0.24+9.7%Rev$1.7M vs ——EODHD
- Q3 FY20232023-11-12EPS$-0.19 vs $-0.22+13.6%Rev$0 vs ——EODHD
- Q2 FY20232023-08-09EPS$-0.22 vs $-0.220.0%Rev$0 vs ——EODHD
- Q1 FY20232023-05-10EPS$-0.26 vs $-0.22-18.2%Rev$0 vs ——EODHD
- Q4 FY20222023-03-29EPS$-0.25 vs $-0.24-4.2%Rev$-9.0K vs ——EODHD
- Q3 FY20222022-11-09EPS$-0.49 vs $-0.45-8.9%Rev$0 vs ——EODHD
- Q2 FY20222022-08-09EPS$-0.44 vs $-0.40-10.0%Rev$265.0K vs ——EODHD
- Q1 FY20222022-05-10EPS$-0.58 vs $-0.52-11.5%Rev$444.0K vs ——EODHD
- Q4 FY20212022-03-30EPS$-0.52 vs $-0.51-2.0%Rev$844.0K vs ——EODHD
- Q3 FY20212021-11-14EPS$-0.48 vs $-0.53+9.4%Rev$574.0K vs ——EODHD
- Q2 FY20212021-08-08EPS$-0.58 vs $-0.69+15.9%Rev$0 vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q1 FY2026 | 2026-05-03 | $-0.24 | $-0.22 | -9.7% | $401.0K | — | — | EODHD |
| Q4 FY2025 | 2026-02-19 | $-0.18 | $-0.21 | +14.3% | $264.0K | — | — | EODHD |
| Q3 FY2025 | 2025-10-28 | $-0.29 | $-0.31 | +6.5% | $86.0K | — | — | EODHD |
| Q2 FY2025 | 2025-08-11 | $-0.28 | $-0.26 | -7.7% | $0 | — | — | EODHD |
| Q1 FY2025 | 2025-05-04 | $-0.25 | — | — | $832.0K | — | — | EODHD |
| Q4 FY2024 | 2025-03-25 | $-0.31 | $-0.24 | -30.2% | $1.7M | — | — | EODHD |
| Q3 FY2024 | 2024-10-29 | $-0.21 | $-0.24 | +13.5% | $0 | — | — | EODHD |
| Q2 FY2024 | 2024-08-18 | $-0.20 | $-0.20 | +0.4% | $0 | — | — | EODHD |
| Q1 FY2024 | 2024-05-06 | $-0.18 | $-0.24 | +23.5% | $0 | — | — | EODHD |
| Q4 FY2023 | 2024-03-27 | $-0.22 | $-0.24 | +9.7% | $1.7M | — | — | EODHD |
| Q3 FY2023 | 2023-11-12 | $-0.19 | $-0.22 | +13.6% | $0 | — | — | EODHD |
| Q2 FY2023 | 2023-08-09 | $-0.22 | $-0.22 | 0.0% | $0 | — | — | EODHD |
| Q1 FY2023 | 2023-05-10 | $-0.26 | $-0.22 | -18.2% | $0 | — | — | EODHD |
| Q4 FY2022 | 2023-03-29 | $-0.25 | $-0.24 | -4.2% | $-9.0K | — | — | EODHD |
| Q3 FY2022 | 2022-11-09 | $-0.49 | $-0.45 | -8.9% | $0 | — | — | EODHD |
| Q2 FY2022 | 2022-08-09 | $-0.44 | $-0.40 | -10.0% | $265.0K | — | — | EODHD |
| Q1 FY2022 | 2022-05-10 | $-0.58 | $-0.52 | -11.5% | $444.0K | — | — | EODHD |
| Q4 FY2021 | 2022-03-30 | $-0.52 | $-0.51 | -2.0% | $844.0K | — | — | EODHD |
| Q3 FY2021 | 2021-11-14 | $-0.48 | $-0.53 | +9.4% | $574.0K | — | — | EODHD |
| Q2 FY2021 | 2021-08-08 | $-0.58 | $-0.69 | +15.9% | $0 | — | — | EODHD |
Source: EODHD. PLSE reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks PLSE's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 60% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.95 | $1.80 | +8.5% | +0.7% | +0.3% |
| Q4 FY2026 | $1.81 | $1.71 | +6.0% | +2.3% | +3.6% |
| Q3 FY2026 | $1.71 | $1.60 | +6.8% | +1.3% | -1.3% |
| Q2 FY2026 | $1.95 | $1.76 | +10.8% | +1.2% | 0.0% |
| Q1 FY2025 | $2.13 | $1.84 | +16.0% | -2.7% | -4.8% |
| Q4 FY2025 | $2.05 | $1.93 | +6.1% | -2.7% | -3.5% |
| Q3 FY2025 | $2.10 | $1.78 | +17.9% | +2.1% | +0.9% |
| Q2 FY2025 | $2.16 | $1.96 | +10.1% | -1.9% | -0.1% |
| Q1 FY2024 | $2.04 | $1.80 | +13.5% | -2.0% | -0.6% |
| Q4 FY2024 | $2.22 | $2.00 | +10.8% | +0.2% | +3.0% |
Guidance change history
Sample- Q1 FY2026Raised2026-04-15
- Q4 FY2026Raised2026-13-15
- Q3 FY2026Raised2026-10-15
- Q2 FY2026Raised2026-07-15
- Q1 FY2025Raised2025-04-15
- Q4 FY2025Raised2025-13-15
- Q3 FY2025Raised2025-10-15
- Q2 FY2025Raised2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Darrin UeckerChief Technology Officer1 yr13 callsCurrentSample
OTHER_C_SUITE since 2025 • 2/4 beats (50%) • last guidance raise Q1 FY2026
- Kevin Patrick DanahyChief Commercial Officer1 yr 11 mono recorded callsCurrentSample
OTHER_C_SUITE since 2024 • 5/8 beats (63%) • last call held guidance Q3 FY2026
- Steven P WeberPrincipal Accounting Officer11 mono recorded callsCurrentSample
OTHER since 2025 • 3/4 beats (75%) • last guidance cut Q1 FY2026
- Paul A LavioletteCEO0 mo5 callsFormerSample
CEO since 2025 • 3/4 beats (75%) • last guidance raise Q3 FY2026
- Burke Thomas BarrettCEO0 mono recorded callsFormerSample
CEO since 2024 • 3/8 beats (38%) • last call held guidance Q2 FY2026
- Mitchell E LevinsonChief Strategy Officer2 mo3 callsFormerSample
OTHER_C_SUITE since 2024 • 4/8 beats (50%) • last guidance raise Q2 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for PLSE.
$ curl https://api.spokenalpha.com/v1/companies/PLSEFAQ
Frequently asked about PLSE
Where can I find PULSE BIOSCIENCES, INC.'s (PLSE) earnings call transcripts?
Spoken Alpha indexes PLSE's earnings call transcripts at https://spokenalpha.com/companies/PLSE. Each call links to attributed speakers and parsed analyst Q&A. PULSE BIOSCIENCES, INC.'s own investor relations page is at https://investor.pulsebiosciences.com/.
When was PULSE BIOSCIENCES, INC.'s most recent earnings call?
PULSE BIOSCIENCES, INC. (PLSE) held its most recent earnings call on 2026-05-07, covering fiscal Q1 2026.
What sector is PLSE in?
PULSE BIOSCIENCES, INC. (PLSE) operates in the Healthcare sector (Medical Instruments & Supplies industry).